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Rm 3215, Maywood, IL 60153, USALower extremity arterial occlusive disease management has
evolved over the 25 years since the publication of this
review in the European Journal of Vascular Surgery. In fact,
this paradigm shift in the management of peripheral arte-
rial disease (PAD) is documented in the change of the
journal’s name to reflect the importance of endovascular
techniques by adding ‘Endovascular’ to its title several
years ago. This statement is true for all facets of care for
patients with arterial and venous disease throughout the
body, but is especially true for patients with lower
extremity occlusive disease.
As physicians, we have become very aggressive with
endovascular solutions to the most complex TASC C and D
lesions throughout the leg. We almost always search for an
endovascular solution first for Rutherford Class 4 or 5
patients. This was certainly not the case in 1995 when Mark
Davies and Per-Otto Hagen published their landmark paper,
“Pathophysiology of Vein Graft Failure: A Review.” A
surgical bypass with a vein graft would have certainly been
the first choice for limb salvage at that time. Therefore,
their review paper was exceptionally relevant at that time
and from my perspective, continues to be very relevant. In
addition, it highlights clearly the limitations of the surgical
bypass procedure that still exist today.
Our current literature tends to focus on the morbidity of
surgical revascularization as a means to justify the use of
complex endovascular techniques. The risk of wound-
healing issues, bleeding, and infection are some of the
more common problems that are identified for patients
undergoing a bypass procedure. Still, a surgical bypass is
a very durable procedure, as compared to a complex endo-
vascular intervention. The advantage of a surgical bypass is
even greater when an autologous conduit is utilized.DOI of original article: 10.1016/S1078-5884(05)80218-7.
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durability of this technique. Drs. Davies and Hagen did an
outstanding job of highlighting the limitations of surgical
bypasses with venous conduits in their review that was pub-
lished over 15 years ago. It is clearly deserving of the high
number of literature citations since its publication. I say this
because of their outstanding description of themechanisms of
failure of vein grafts. This paper should beamandatory part of
the vascular surgery curriculum for our trainees, so that they
can appropriately learn the timing of bypass graft failure. It
will also allow them to understand (better) why bypass graft
failure occurs in the longer-term (greater than 2 years).
I found several statements in this paper particularly
useful to modern day practice. The authors say that “up to
30% of vein grafts will require intervention within two years
due to the development of haemodynamically significant
intimal hyperplastic lesions (graft stenosis).” This high
number clearly justifies the role of semi-annual duplex
surveillance for the maintenance of venous bypass grafts.
They describe “that every effort should be made to
reduce the degree of implantation injury that a vein graft
suffers.” This implantation injury includes the storage of
the vein graft in physiologic solutions; management of
valves during in situ surgical bypass; and the amount of
pressurization during inflation of a harvested vein graft.
These pointers are still very relevant technical reminders to
even the most experienced vascular surgeon of today.
When describing vein graft failure, they say that “intimal
hyperplasia is the universal response of a vein graft to its
insertion into the arterial circulation.” And, they go on to
say that “the precise initiating stimuli for intimal hyper-
plasia have not been fully defined, but appears to be the
response of the vascular smooth muscle cells to a combina-
tion of physical, cellular and humoral factors accompanied
by dysfunctional endothelial regulation.” Both of these
statements are relatively disappointing to me. I make this
comment because our understanding of intimal hyperplasia
and its underlying mechanism in 2011 are not dramaticallyd by Elsevier Ltd. All rights reserved.
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1995. A significant amount of time, energy, and money has
been devoted to clarifying the process of intimal hyper-
plasia in order to prevent bypass graft failure. A statement
written in a similar type of review in 2011 would not appear
much different than the 1995 review despite this tremen-
dous research effort.
The authors describe that “under hyperlipidemic condi-
tions, venous tissue demonstrate an avidity for the uptake
of serum lipid surpassing that of arterial tissue in the same
species.” I am more optimistic about this statement by the
authors. Since 1995, we have become much more sophisti-
cated regarding the medical management of our vascular
patients and improved cholesterol management in patients
with lower extremity arterial disease may potentially have
a positive impact on bypass graft durability.Finally, Davies and Hagen say that “no effective clinical
regimen is presently available to counter the intimal
hyperplastic response found in vein grafts.” And; “at
present, intimal hyperplasia is the principal impediment to
more durable vein grafts. Our growing understanding of the
pathobiology of vein grafts will ultimately produce prac-
tical therapeutic strategies to enhance graft function and
control intimal hyperplasia.” These concluding sentences
are still very relevant today.
I would like to congratulate the authors for producing
a review paper that has been cited so frequently. In addi-
tion, they deserve accolades for providing a body of work
that is relevant over a decade later, despite the many
advances in Vascular Surgery research tools and techniques.
This paper is a salient reminder that we still have historical
problems that need to be resolved.
